Experience with Administration of Ruxolitinib after Allogeneic Stem Cell Transplantation (alloSCT) in Patients with Myelofibrosis

被引：2
|
作者：
Tipirneni, Eswar [1 ]
Kodali, Saranya [2 ]
Ramanathan, Muthalagu [1 ]
Nath, Rajneesh [1 ]
Cerny, Jan [1 ]
机构：
[1] Univ Massachusetts, Dept Med, Div Hematol Oncol, Worcester, MA 01605 USA
[2] Univ Massachusetts, Dept Med, Worcester, MA 01605 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2014.11.502
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
456
引用
收藏
页码：S315 / S316
页数：2
相关论文
共 50 条
  • [21] Allogeneic stem cell transplantation (AlloSCT) in patients with lymphoma relapsing after autologous SCT (AutoSCT)
    Aurer, I
    Bogdanic, V
    Nemet, D
    Mrsic, M
    Labar, B
    ANNALS OF ONCOLOGY, 1998, 9 : 114 - 114
  • [22] Allogeneic Stem Cell Transplantation in Myelofibrosis
    Jain, Tania
    Mesa, Ruben A.
    Palmer, Jeanne M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1429 - 1436
  • [23] Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis Treated With Ruxolitinib in The Pre-Transplant Period
    Mensah-Glanowska, Patrycja
    Szeremet, Agnieszka
    Nasilowska-Adamska, Barbara
    Majcherek, Maciej
    Jakubas, Beata
    Halaburda, Kazimierz
    Wrobel, Tomasz
    Czyz, Anna
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 146 - 147
  • [24] EASIX for Predicting SOS/VOD after Allogeneic Stem Cell Transplantation (alloSCT)
    Penack, Olaf
    Jiang, Sihe
    Benner, Axel
    Radujkovic, Aleksandar
    Dreger, Peter
    Luft, Thomas
    BONE MARROW TRANSPLANTATION, 2018, 53 : 321 - 322
  • [25] Ruxolitinib Maintenance Post Myelofibrosis Allogeneic Stem Cell Transplant
    Pu, Jeffrey J.
    Poulose, Joyson
    Zhu, Junjia
    Malysz, Jozef
    Fanburg-Smith, Julie
    Bayerl, Michael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [26] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MYELOFIBROSIS: EXPERIENCE OF 4 CENTERS
    Benzaquen, A.
    Correa, J. G.
    De la Puerta, R.
    Saez-Marin, A.
    Hernani, R.
    Rovira, M.
    Mora, E.
    Perez, A.
    Montoro, J.
    Sanz, J.
    Solano, C.
    Garcia-Gutierrez, V
    Pinana, J. L.
    Alvarez-Larran, A.
    Cervantes, F.
    Hernandez-Boluda, J. C.
    HAEMATOLOGICA, 2019, 104 : 35 - 36
  • [27] Allogeneic stem cell transplantation in myelofibrosis; a single-centre experience
    Remes, K.
    Toivari, A.
    Kauppila, M.
    Putkonen, M.
    Itala-Remes, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S366 - S366
  • [28] Allogeneic stem cell transplantation in idiopathic myelofibrosis: The Italian experience.
    Patriarca, Francesca F.
    Sperotto, Alessandra A.
    Bruno, Barbara B.
    Bacigalupo, Andrea A.
    Bosi, Alberto A.
    Fanin, Renato R.
    BLOOD, 2006, 108 (11) : 853A - 853A
  • [29] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MYELOFIBROSIS: SINGLE CENTER EXPERIENCE
    Nishihori, T.
    Perkins, J.
    Pidala, J.
    Roman, J.
    Kim, J.
    Fernandez, H.
    Anasetti, C.
    Kharfan-Dabaja, M. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S293 - S293
  • [30] The Role of Ruxolitinib Therapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Primary Myelofibrosis
    Oshima, Koichi
    Arakawa, Yuki
    Hiraki, Takamasa
    Inoue, Kyohei
    Mitani, Yuichi
    Mori, Makiko
    Fukuoka, Kohei
    Nakazawa, Atsuko
    Koh, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2020, 67
12345